in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Cambrex reports fall in profits
10:48 AM MST | February 11, 2014 | Deepti Ramesh
Cambrex (East Rutherford, NJ) reports a 79.6% fall in net profits for the fourth quarter of 2013, ended 31 December, compared with the year-ago quarter, to $8.89 million. The results for the fourth quarter of 2012 include tax benefits of $37.6 million, Cambrex says. Net sales for fourth-quarter 2013 increased 47%, however, to $102.4 million, primarily because of higher sales of a recently approved branded active pharmaceutical ingredient (API) and controlled substances, partially offset by lower sales of generic and other branded APIs and products using the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee